Browsing Centre for Experimental Medicine and Rheumatology (EMR) by Author "Ehrenstein, MR"
Now showing items 1-4 of 4
-
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.
Cope, AP; Barnes, MR; Belson, A; Binks, M; Brockbank, S; Bonachela-Capdevila, F; Carini, C; Fisher, BA; Goodyear, CS; Emery, P (2018-01-24)This corrects the article DOI: 10.1038/nrrheum.2017.200. -
The RA-MAP Consortium: a working model for academia-industry collaboration
Cope, AP; Barnes, MR; Belson, A; Binks, M; Brockbank, S; Bonachela-Capdevila, F; Carini, C; Fisher, BA; Goodyear, CS; Emery, P (2018-01) -
RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
Isaacs, JD; Brockbank, S; Pedersen, AW; Hilkens, C; Anderson, A; Stocks, P; Lendrem, D; Tarn, J; Smith, GR; Allen, B (2022) -
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials
Rivellese, F; Nerviani, A; Giorli, G; Warren, L; Jaworska, E; Bombardieri, M; Lewis, MJ; Humby, F; Pratt, AG; Filer, A (2023-11-01)Background: Despite highly effective targeted therapies for rheumatoid arthritis, about 40% of patients respond poorly, and predictive biomarkers for treatment choices are lacking. We did a biopsy-driven trial to compare ...